Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors

被引:0
作者
Romero-Corral, Abel [1 ]
Somers, Virend K. [1 ]
Korinek, Josef [1 ]
Sierra-Johnson, Justo [1 ]
Thomas, Randal J. [1 ]
Allison, Thomas G. [1 ]
Lopez-Jimenez, Francisco [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2006年 / 58卷 / 03期
关键词
cardiovascular disease; update; prevention; risk factors; atherosclerosis; dyslipidemia; hypertension; diabetes; smoking cessation; obesity; obstructive sleep apnea;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) remains as the first cause of death worldwide. Scientific community works everyday trying to ameliorate this burden. Only in the year 2004 around 2,790 publications about the therapeutic use of antihypertensive agents can be found in MEDLINE. Despite this overwhelming effort and information, only a relatively short number of manuscripts have a real impact in clinical practice. For the busy clinician, it becomes almost impossible to screen and be updated with the landmark publications. The purpose of this article is to provide concise information related to prevention of CVD. We reviewed publications in the past 5 years regarding cardiovascular risk factors with special attention to dyslipidemia, hypertension, diabetes, smoking cessation and obesity, discussing some new findings and treatments. We also discuss obstructive sleep apnea (OSA) as a recently identified cardiovascular risk factor, and provide a general overview about its pathophysiology and treatment.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 54 条
[1]  
[Anonymous], 2002, JAMA
[2]  
BATSIS JA, 2006, IN PRESS J AM COLL C
[3]   Global cardiovascular disease prevention: time to get serious [J].
Beaglehole, R .
LANCET, 2001, 358 (9282) :661-663
[4]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[5]  
BOBADILLA JL, 1993, EPIDEMIOLOGIC TRANSI, P351
[6]   Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[7]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[8]   Obstructive sleep apnea [J].
Caples, SM ;
Gami, AS ;
Somers, VK .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (03) :187-197
[9]  
Chávez Domínguez Rafael, 2003, Arch. Cardiol. Méx., V73, P105
[10]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3